Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.04 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enriched outside the brain (hepatocytes) | 0.10 |
| chemistry Open Targets | a small-molecule pocket: fibrinolysin, human, fibrinogen, human, plasminogen +2 | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 1,031 | 0.91 |
| pathways Reactome | 21 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 6176
Sealed predictions
- FGG in dopamine neurons, braak+0.20 (p 0.597) → +0.65 (p 0.060)receipt 6183
Swarm cases
receipt 6183: FGG in dopamine neurons, braak
- power
- full sample +0.39 (p 0.109, n 18), 95% CI -0.09 to +0.73. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.45 (p 0.060, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.42 (p 0.082, n 18). could be the mix.
- skeptic
- leave-one-out range +0.33 to +0.57, sign flips 0; without severely affected donors +0.39 (p 0.109, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FGG in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts